πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 179 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11447452

Agonists of peroxisome proliferator-activated receptor alpha and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11446365

Antimalarial enzyme conjugates, kits containing same, and methods of producing and using s

The Board of Regents of the University of Oklahoma Β· Granted Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11414458

Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA t

The Board of Regents of the University of Oklahoma Β· Granted Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11369575

PPARΞ± agonist compositions and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11337968

Phenylquinoline compositions for treatment of ocular disorders and conditions

The Board of Regents of the University of Oklahoma Β· Granted Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11311526

Radiation mitigator and method of use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11305002

Compositions and treatments for Haemophilus influenzae

The Board of Regents of the University of Oklahoma Β· Granted Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11230569

Antiplasmodial compounds

The Board of Regents of the University of Oklahoma Β· Granted Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11203582

Benzamide derivatives for inhibiting endoplasmic reticulum (ER) stress

The Board of Regents of the University of Oklahoma Β· Granted Tue Dec 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11180452

Methods and compositions for selectively inhibiting pathogenic microbes

The Board of Regents of the University of Oklahoma Β· Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10975124

Methods and compositions for treating diseases and conditions associated with gonadotropin

The Board of Regents of the University of Oklahoma Β· Granted Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10953040

Methods of treating bacterial infections with penam Ξ²-lactam antibiotics and branched poly

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10953113

Imaging agents and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10933126

Clostridium difficile immunogenic compositions and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10899822

Compositions comprising D-amino acid peptides and methods of production and use thereof fo

The Board of Regents of the University of Oklahoma Β· Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10876116

Anti-ARID3a treatments for inflammatory disorders

The Board of Regents of the University of Oklahoma Β· Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10815219

2,4-diaminoquinazoline derivatives for inhibiting endoplasmic reticulum (ER) stress

The Board of Regents of the University of Oklahoma Β· Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10779517

Animal wound model and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10723778

Variants of adrenomedullin and calcitonin gene-related peptide and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10709758

Peptide inhibitors of clostridium difficile toxin B (TcdB) toxin

The Board of Regents of the University of Oklahoma Β· Granted Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10640535

Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA t

The Board of Regents of the University of Oklahoma Β· Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10584306

Surfactant microemulsions

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10562941

Pneumolysin mutants and methods of use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10494619

High isomerohydrolase activity mutants of human RPE65

The Board of Regents of the University of Oklahoma Β· Granted Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted